Hypertension and cardiovascular disease: contributions of the framingham heart study.
about
Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases.Longitudinal Trends in Hypertension Management and Mortality Among Octogenarians: Prospective Cohort StudyInteraction between Mean Arterial Pressure and HbA1c in Prediction of Cardiovascular Disease Hospitalisation: A Population-Based Case-Control StudyEvaluation of Lipid Profile and Apolipoproteins in Essential Hypertensive Patients.Frequency of eating home cooked meals and potential benefits for diet and health: cross-sectional analysis of a population-based cohort study.Dietary total antioxidant capacity is inversely associated with all-cause and cardiovascular disease death of US adults.Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons.Polymorphisms of extrinsic death receptor apoptotic genes (FAS -670 G>A, FASL -844 T>C) in coronary artery disease.Prospective associations between pulse pressure and cognitive performance in Chinese middle-aged and older population across a 5-year study period.Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).Impact of Obesity and Ozone on the Association Between Particulate Air Pollution and Cardiovascular Disease and Stroke Mortality Among US Adults.Utilizing proteomics to understand and define hypertension: where are we and where do we go?Prevalence and Risk Factors of Hypertension in Two Communes in the Vietnam Northern Mountainous, 2017
P2860
Q36451708-1268A7EB-CE5A-4F55-A702-86AE915B517CQ36988076-298D2622-7473-431B-A2A6-F1AD32D95C66Q37039378-B21A1ACC-B5F5-46DB-A078-3817EC5A725CQ37435355-E9892DE6-6CAF-4906-A9DD-0886DD11C0D8Q38619623-A5E918FD-4B50-432E-A29D-7B76162557F3Q38632848-99EA73C3-E5D0-4C85-A9DA-6E7A9B923A7FQ38849711-2569F5FF-75A0-49BB-BDA7-2AAE06F5A2FCQ39550978-9ED84909-1B16-4548-9CF6-C9E43D2A0174Q40883676-0DB00D1D-1951-4510-ABAA-1A02A505CD1AQ51763925-4F8E9612-4052-4EF5-80AB-7921D1B5251FQ55260519-9CE2A9C3-1D6B-4259-93BB-13C10202109AQ55444847-6515CC03-9BEF-4483-ACE7-903689F39590Q58227790-32FF3A34-CF7D-4FF9-A9D9-C1607F63DC90Q58577691-96F10791-8F36-4F7E-8FAB-A78D491493CB
P2860
Hypertension and cardiovascular disease: contributions of the framingham heart study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Hypertension and cardiovascular disease: contributions of the framingham heart study.
@en
type
label
Hypertension and cardiovascular disease: contributions of the framingham heart study.
@en
prefLabel
Hypertension and cardiovascular disease: contributions of the framingham heart study.
@en
P1433
P1476
Hypertension and cardiovascular disease: contributions of the framingham heart study.
@en
P2093
Nathan D Wong
Stanley S Franklin
P356
10.1016/J.GHEART.2012.12.004
P577
2013-03-15T00:00:00Z